Clinical Trial Update: Juvenile Idiopathic Arthritis (JIA) Registry

View source ↗

Summary

AbbVie-sponsored Juvenile Idiopathic Arthritis (JIA) registry has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: AbbVie | Conditions: Juvenile Idiopathic Arthritis, JIA | Status: COMPLETED